The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Nucleic Acid Non-Denaturing Precast Gel Market Research Report 2024

Global Nucleic Acid Non-Denaturing Precast Gel Market Research Report 2024

Publishing Date : Aug, 2023

License Type :
 

Report Code : 1765040

No of Pages : 107

Synopsis
Nucleic acid non-denaturing precast gels are suitable for DNA electrophoresis applications, including analysis of restriction enzymes, PCR products, Southern blot analysis, and primer analysis.

Global Nucleic Acid Non-Denaturing Precast Gel market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Nucleic Acid Non-Denaturing Precast Gel market research.

Key manufacturers engaged in the Nucleic Acid Non-Denaturing Precast Gel industry include Thermo Fisher Scientific, Bio-Rad, GenScript Biotech, AAT Bioquest, Interchim, Norgen Biotek, Abbexa, Promega and ABclonal, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Nucleic Acid Non-Denaturing Precast Gel were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Nucleic Acid Non-Denaturing Precast Gel market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Nucleic Acid Non-Denaturing Precast Gel market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Thermo Fisher Scientific
  • Bio-Rad
  • GenScript Biotech
  • AAT Bioquest
  • Interchim
  • Norgen Biotek
  • Abbexa
  • Promega
  • ABclonal
  • Absin
  • Shanghai Wansheng Haotian Biotechnology
  • Smart-lifesciences
  • Shanghai Lmai Bioengineering
  • Beijing Solarbio Science & Technology
  • Changzhou Boyi Biotech

Segment by Type

  • Concentration 5%
  • Concentration 10%
  • Concentration 15%
  • Concentration 20%
  • Others

Segment by Application

  • Academic Research Institution
  • Hospitals And Diagnostic Centers
  • Biopharmaceutical
  • Others

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Nucleic Acid Non-Denaturing Precast Gel report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

1 Nucleic Acid Non-Denaturing Precast Gel Market Overview
1.1 Product Overview and Scope of Nucleic Acid Non-Denaturing Precast Gel
1.2 Nucleic Acid Non-Denaturing Precast Gel Segment by Type
1.2.1 Global Nucleic Acid Non-Denaturing Precast Gel Market Value Comparison by Type (2023-2029)
1.2.2 Concentration 5%
1.2.3 Concentration 10%
1.2.4 Concentration 15%
1.2.5 Concentration 20%
1.2.6 Others
1.3 Nucleic Acid Non-Denaturing Precast Gel Segment by Application
1.3.1 Global Nucleic Acid Non-Denaturing Precast Gel Market Value by Application: (2023-2029)
1.3.2 Academic Research Institution
1.3.3 Hospitals And Diagnostic Centers
1.3.4 Biopharmaceutical
1.3.5 Others
1.4 Global Nucleic Acid Non-Denaturing Precast Gel Market Size Estimates and Forecasts
1.4.1 Global Nucleic Acid Non-Denaturing Precast Gel Revenue 2018-2029
1.4.2 Global Nucleic Acid Non-Denaturing Precast Gel Sales 2018-2029
1.4.3 Global Nucleic Acid Non-Denaturing Precast Gel Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Nucleic Acid Non-Denaturing Precast Gel Market Competition by Manufacturers
2.1 Global Nucleic Acid Non-Denaturing Precast Gel Sales Market Share by Manufacturers (2018-2023)
2.2 Global Nucleic Acid Non-Denaturing Precast Gel Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Nucleic Acid Non-Denaturing Precast Gel Average Price by Manufacturers (2018-2023)
2.4 Global Nucleic Acid Non-Denaturing Precast Gel Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Nucleic Acid Non-Denaturing Precast Gel, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nucleic Acid Non-Denaturing Precast Gel, Product Type & Application
2.7 Nucleic Acid Non-Denaturing Precast Gel Market Competitive Situation and Trends
2.7.1 Nucleic Acid Non-Denaturing Precast Gel Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Nucleic Acid Non-Denaturing Precast Gel Players Market Share by Revenue
2.7.3 Global Nucleic Acid Non-Denaturing Precast Gel Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Nucleic Acid Non-Denaturing Precast Gel Retrospective Market Scenario by Region
3.1 Global Nucleic Acid Non-Denaturing Precast Gel Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Nucleic Acid Non-Denaturing Precast Gel Global Nucleic Acid Non-Denaturing Precast Gel Sales by Region: 2018-2029
3.2.1 Global Nucleic Acid Non-Denaturing Precast Gel Sales by Region: 2018-2023
3.2.2 Global Nucleic Acid Non-Denaturing Precast Gel Sales by Region: 2024-2029
3.3 Global Nucleic Acid Non-Denaturing Precast Gel Global Nucleic Acid Non-Denaturing Precast Gel Revenue by Region: 2018-2029
3.3.1 Global Nucleic Acid Non-Denaturing Precast Gel Revenue by Region: 2018-2023
3.3.2 Global Nucleic Acid Non-Denaturing Precast Gel Revenue by Region: 2024-2029
3.4 North America Nucleic Acid Non-Denaturing Precast Gel Market Facts & Figures by Country
3.4.1 North America Nucleic Acid Non-Denaturing Precast Gel Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Nucleic Acid Non-Denaturing Precast Gel Sales by Country (2018-2029)
3.4.3 North America Nucleic Acid Non-Denaturing Precast Gel Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Nucleic Acid Non-Denaturing Precast Gel Market Facts & Figures by Country
3.5.1 Europe Nucleic Acid Non-Denaturing Precast Gel Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Nucleic Acid Non-Denaturing Precast Gel Sales by Country (2018-2029)
3.5.3 Europe Nucleic Acid Non-Denaturing Precast Gel Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nucleic Acid Non-Denaturing Precast Gel Market Facts & Figures by Country
3.6.1 Asia Pacific Nucleic Acid Non-Denaturing Precast Gel Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Nucleic Acid Non-Denaturing Precast Gel Sales by Country (2018-2029)
3.6.3 Asia Pacific Nucleic Acid Non-Denaturing Precast Gel Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Nucleic Acid Non-Denaturing Precast Gel Market Facts & Figures by Country
3.7.1 Latin America Nucleic Acid Non-Denaturing Precast Gel Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Nucleic Acid Non-Denaturing Precast Gel Sales by Country (2018-2029)
3.7.3 Latin America Nucleic Acid Non-Denaturing Precast Gel Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Nucleic Acid Non-Denaturing Precast Gel Market Facts & Figures by Country
3.8.1 Middle East and Africa Nucleic Acid Non-Denaturing Precast Gel Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Nucleic Acid Non-Denaturing Precast Gel Sales by Country (2018-2029)
3.8.3 Middle East and Africa Nucleic Acid Non-Denaturing Precast Gel Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nucleic Acid Non-Denaturing Precast Gel Sales by Type (2018-2029)
4.1.1 Global Nucleic Acid Non-Denaturing Precast Gel Sales by Type (2018-2023)
4.1.2 Global Nucleic Acid Non-Denaturing Precast Gel Sales by Type (2024-2029)
4.1.3 Global Nucleic Acid Non-Denaturing Precast Gel Sales Market Share by Type (2018-2029)
4.2 Global Nucleic Acid Non-Denaturing Precast Gel Revenue by Type (2018-2029)
4.2.1 Global Nucleic Acid Non-Denaturing Precast Gel Revenue by Type (2018-2023)
4.2.2 Global Nucleic Acid Non-Denaturing Precast Gel Revenue by Type (2024-2029)
4.2.3 Global Nucleic Acid Non-Denaturing Precast Gel Revenue Market Share by Type (2018-2029)
4.3 Global Nucleic Acid Non-Denaturing Precast Gel Price by Type (2018-2029)
5 Segment by Application
5.1 Global Nucleic Acid Non-Denaturing Precast Gel Sales by Application (2018-2029)
5.1.1 Global Nucleic Acid Non-Denaturing Precast Gel Sales by Application (2018-2023)
5.1.2 Global Nucleic Acid Non-Denaturing Precast Gel Sales by Application (2024-2029)
5.1.3 Global Nucleic Acid Non-Denaturing Precast Gel Sales Market Share by Application (2018-2029)
5.2 Global Nucleic Acid Non-Denaturing Precast Gel Revenue by Application (2018-2029)
5.2.1 Global Nucleic Acid Non-Denaturing Precast Gel Revenue by Application (2018-2023)
5.2.2 Global Nucleic Acid Non-Denaturing Precast Gel Revenue by Application (2024-2029)
5.2.3 Global Nucleic Acid Non-Denaturing Precast Gel Revenue Market Share by Application (2018-2029)
5.3 Global Nucleic Acid Non-Denaturing Precast Gel Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Thermo Fisher Scientific
6.1.1 Thermo Fisher Scientific Corporation Information
6.1.2 Thermo Fisher Scientific Description and Business Overview
6.1.3 Thermo Fisher Scientific Nucleic Acid Non-Denaturing Precast Gel Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Thermo Fisher Scientific Nucleic Acid Non-Denaturing Precast Gel Product Portfolio
6.1.5 Thermo Fisher Scientific Recent Developments/Updates
6.2 Bio-Rad
6.2.1 Bio-Rad Corporation Information
6.2.2 Bio-Rad Description and Business Overview
6.2.3 Bio-Rad Nucleic Acid Non-Denaturing Precast Gel Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Bio-Rad Nucleic Acid Non-Denaturing Precast Gel Product Portfolio
6.2.5 Bio-Rad Recent Developments/Updates
6.3 GenScript Biotech
6.3.1 GenScript Biotech Corporation Information
6.3.2 GenScript Biotech Description and Business Overview
6.3.3 GenScript Biotech Nucleic Acid Non-Denaturing Precast Gel Sales, Revenue and Gross Margin (2018-2023)
6.3.4 GenScript Biotech Nucleic Acid Non-Denaturing Precast Gel Product Portfolio
6.3.5 GenScript Biotech Recent Developments/Updates
6.4 AAT Bioquest
6.4.1 AAT Bioquest Corporation Information
6.4.2 AAT Bioquest Description and Business Overview
6.4.3 AAT Bioquest Nucleic Acid Non-Denaturing Precast Gel Sales, Revenue and Gross Margin (2018-2023)
6.4.4 AAT Bioquest Nucleic Acid Non-Denaturing Precast Gel Product Portfolio
6.4.5 AAT Bioquest Recent Developments/Updates
6.5 Interchim
6.5.1 Interchim Corporation Information
6.5.2 Interchim Description and Business Overview
6.5.3 Interchim Nucleic Acid Non-Denaturing Precast Gel Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Interchim Nucleic Acid Non-Denaturing Precast Gel Product Portfolio
6.5.5 Interchim Recent Developments/Updates
6.6 Norgen Biotek
6.6.1 Norgen Biotek Corporation Information
6.6.2 Norgen Biotek Description and Business Overview
6.6.3 Norgen Biotek Nucleic Acid Non-Denaturing Precast Gel Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Norgen Biotek Nucleic Acid Non-Denaturing Precast Gel Product Portfolio
6.6.5 Norgen Biotek Recent Developments/Updates
6.7 Abbexa
6.6.1 Abbexa Corporation Information
6.6.2 Abbexa Description and Business Overview
6.6.3 Abbexa Nucleic Acid Non-Denaturing Precast Gel Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Abbexa Nucleic Acid Non-Denaturing Precast Gel Product Portfolio
6.7.5 Abbexa Recent Developments/Updates
6.8 Promega
6.8.1 Promega Corporation Information
6.8.2 Promega Description and Business Overview
6.8.3 Promega Nucleic Acid Non-Denaturing Precast Gel Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Promega Nucleic Acid Non-Denaturing Precast Gel Product Portfolio
6.8.5 Promega Recent Developments/Updates
6.9 ABclonal
6.9.1 ABclonal Corporation Information
6.9.2 ABclonal Description and Business Overview
6.9.3 ABclonal Nucleic Acid Non-Denaturing Precast Gel Sales, Revenue and Gross Margin (2018-2023)
6.9.4 ABclonal Nucleic Acid Non-Denaturing Precast Gel Product Portfolio
6.9.5 ABclonal Recent Developments/Updates
6.10 Absin
6.10.1 Absin Corporation Information
6.10.2 Absin Description and Business Overview
6.10.3 Absin Nucleic Acid Non-Denaturing Precast Gel Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Absin Nucleic Acid Non-Denaturing Precast Gel Product Portfolio
6.10.5 Absin Recent Developments/Updates
6.11 Shanghai Wansheng Haotian Biotechnology
6.11.1 Shanghai Wansheng Haotian Biotechnology Corporation Information
6.11.2 Shanghai Wansheng Haotian Biotechnology Nucleic Acid Non-Denaturing Precast Gel Description and Business Overview
6.11.3 Shanghai Wansheng Haotian Biotechnology Nucleic Acid Non-Denaturing Precast Gel Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Shanghai Wansheng Haotian Biotechnology Nucleic Acid Non-Denaturing Precast Gel Product Portfolio
6.11.5 Shanghai Wansheng Haotian Biotechnology Recent Developments/Updates
6.12 Smart-lifesciences
6.12.1 Smart-lifesciences Corporation Information
6.12.2 Smart-lifesciences Nucleic Acid Non-Denaturing Precast Gel Description and Business Overview
6.12.3 Smart-lifesciences Nucleic Acid Non-Denaturing Precast Gel Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Smart-lifesciences Nucleic Acid Non-Denaturing Precast Gel Product Portfolio
6.12.5 Smart-lifesciences Recent Developments/Updates
6.13 Shanghai Lmai Bioengineering
6.13.1 Shanghai Lmai Bioengineering Corporation Information
6.13.2 Shanghai Lmai Bioengineering Nucleic Acid Non-Denaturing Precast Gel Description and Business Overview
6.13.3 Shanghai Lmai Bioengineering Nucleic Acid Non-Denaturing Precast Gel Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Shanghai Lmai Bioengineering Nucleic Acid Non-Denaturing Precast Gel Product Portfolio
6.13.5 Shanghai Lmai Bioengineering Recent Developments/Updates
6.14 Beijing Solarbio Science & Technology
6.14.1 Beijing Solarbio Science & Technology Corporation Information
6.14.2 Beijing Solarbio Science & Technology Nucleic Acid Non-Denaturing Precast Gel Description and Business Overview
6.14.3 Beijing Solarbio Science & Technology Nucleic Acid Non-Denaturing Precast Gel Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Beijing Solarbio Science & Technology Nucleic Acid Non-Denaturing Precast Gel Product Portfolio
6.14.5 Beijing Solarbio Science & Technology Recent Developments/Updates
6.15 Changzhou Boyi Biotech
6.15.1 Changzhou Boyi Biotech Corporation Information
6.15.2 Changzhou Boyi Biotech Nucleic Acid Non-Denaturing Precast Gel Description and Business Overview
6.15.3 Changzhou Boyi Biotech Nucleic Acid Non-Denaturing Precast Gel Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Changzhou Boyi Biotech Nucleic Acid Non-Denaturing Precast Gel Product Portfolio
6.15.5 Changzhou Boyi Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nucleic Acid Non-Denaturing Precast Gel Industry Chain Analysis
7.2 Nucleic Acid Non-Denaturing Precast Gel Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nucleic Acid Non-Denaturing Precast Gel Production Mode & Process
7.4 Nucleic Acid Non-Denaturing Precast Gel Sales and Marketing
7.4.1 Nucleic Acid Non-Denaturing Precast Gel Sales Channels
7.4.2 Nucleic Acid Non-Denaturing Precast Gel Distributors
7.5 Nucleic Acid Non-Denaturing Precast Gel Customers
8 Nucleic Acid Non-Denaturing Precast Gel Market Dynamics
8.1 Nucleic Acid Non-Denaturing Precast Gel Industry Trends
8.2 Nucleic Acid Non-Denaturing Precast Gel Market Drivers
8.3 Nucleic Acid Non-Denaturing Precast Gel Market Challenges
8.4 Nucleic Acid Non-Denaturing Precast Gel Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’